within Pharmacolibrary.Drugs.ATC.C;

model C09DX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.37 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 16 / 1000000,
    adminCount     = 1,
    Vd             = 0.017,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fixed-dose combination of candesartan (an angiotensin II receptor blocker), amlodipine (a calcium channel blocker), and hydrochlorothiazide (a thiazide diuretic). Used in the treatment of hypertension (high blood pressure) to lower blood pressure and reduce risk of cardiovascular events. Approved for use in several countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies found for the triple fixed-dose combination C09DX06; PK parameters estimated from individual component population PK data in healthy adults.</p><h4>References</h4><ol><li><p>Pandey, AK, et al., &amp; Malhotra, S (2020). Pharmacokinetic and pharmacodynamic evaluation of nano-fixed dose combination for hypertension. <i>Journal of hypertension</i> 38(8) 1593–1602. DOI:<a href=&quot;https://doi.org/10.1097/HJH.0000000000002429&quot;>10.1097/HJH.0000000000002429</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32371763/&quot;>https://pubmed.ncbi.nlm.nih.gov/32371763</a></p></li><li><p>Ferri, N, &amp; Corsini, A (2025). [Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases]. <i>Giornale italiano di cardiologia (2006)</i> 26(1 Suppl 2) e6–e16. DOI:<a href=&quot;https://doi.org/10.1714/4425.44225&quot;>10.1714/4425.44225</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39898749/&quot;>https://pubmed.ncbi.nlm.nih.gov/39898749</a></p></li><li><p>McClellan, KJ, &amp; Jarvis, B (2000). Lercanidipine: a review of its use in hypertension. <i>Drugs</i> 60(5) 1123–1140. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200060050-00009&quot;>10.2165/00003495-200060050-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11129125/&quot;>https://pubmed.ncbi.nlm.nih.gov/11129125</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09DX06;
